EternaTear is a company headquartered in the United States.
EternaTear develops a novel artificial tear technology designed to provide longer-lasting relief for dry eye syndrome by mimicking natural tears and reducing the frequency of application.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.